QuidelOrtho (QDEL)

Nasdaq Health Care Health Care Supplies S&P SmallCap 600

$10.70

-2.14 (-16.67%)

Close of Nov 06, 2026 · end-of-day data

Source: QuidelOrtho's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2021	FY2022	FY2023	FY2023	FY2024	FY2025
Revenue	$1.66B	$1.70B	$3.27B	$3.00B	$2.78B	$2.73B
Cost of revenue	$305.40M	$420.30M	$1.33B	$1.50B	$1.50B	$1.46B
Gross profit	$1.36B	$1.28B	$1.94B	$1.50B	$1.29B	$1.27B
Research & development	$84.30M	$95.70M	$187.90M	$245.00M	$218.70M	$186.20M
Selling, general & admin	$180.70M	$239.60M	$621.00M	$763.20M	$766.80M	$746.30M
Operating income	$1.06B	$906.00M	$843.70M	$139.10M	-$1.96B	-$919.20M
Interest expense	—	—	$75.70M	$147.60M	$163.50M	$177.60M
Pre-tax income	$1.04B	$900.30M	$735.90M	-$29.10M	-$2.13B	-$1.11B
Income tax	$230.00M	$196.10M	$187.20M	-$19.00M	-$79.50M	$24.10M
Net income	$810.30M	$704.20M	$548.70M	-$10.10M	-$2.05B	-$1.13B
EBITDA	$1.11B	$958.70M	$1.13B	$596.30M	-$1.51B	-$477.20M
EPS (basic)	$19.24	$16.74	$9.66	$-0.15	$-30.54	$-16.69
EPS (diluted)	$18.60	$16.43	$9.56	$-0.15	$-30.54	$-16.69
Diluted shares	43.60M	42.90M	57.40M	66.80M	67.20M	67.80M
Gross margin	81.6%	75.3%	59.3%	49.9%	46.2%	46.7%
Operating margin	63.8%	53.3%	25.8%	4.6%	-70.5%	-33.7%
Net margin	48.8%	41.5%	16.8%	-0.3%	-73.7%	-41.5%

Balance sheet

fiscal years · USD

Fiscal year	FY2021	FY2022	FY2023	FY2023	FY2024	FY2025
Cash & equivalents	$489.90M	$802.80M	$292.90M	$118.90M	$98.30M	$169.80M
Short-term investments	—	$25.70M	$52.10M	$48.40M	$0	—
Receivables	—	$378.00M	$453.90M	$303.30M	$282.40M	$417.00M
Inventory	—	$198.80M	$524.10M	$577.80M	$533.70M	$577.60M
Total current assets	—	$1.44B	$1.58B	$1.31B	$1.22B	$1.45B
Goodwill	—	$337.00M	$2.48B	$2.49B	$649.50M	$0
Total assets	—	$2.43B	$8.86B	$8.56B	$6.42B	$5.77B
Total current liabilities	—	$323.50M	$1.01B	$833.80M	$998.80M	$966.10M
Short-term debt	—	$300.00K	$207.50M	$139.80M	$341.80M	$178.30M
Long-term debt	—	$700.00K	$2.65B	$2.42B	$2.49B	$2.70B
Total debt	—	$1.00M	$2.86B	$2.56B	$2.83B	$2.88B
Total liabilities	—	$501.00M	$3.92B	$3.56B	$3.44B	$3.85B
Shareholders' equity	$1.33B	$1.93B	$4.93B	$5.01B	$2.98B	$1.92B

Cash flow

fiscal years · USD

Fiscal year	FY2021	FY2022	FY2023	FY2023	FY2024	FY2025
Operating cash flow	$629.70M	$805.90M	$885.30M	$280.20M	$83.00M	$105.20M
Capital expenditures	$64.90M	$292.80M	$140.90M	$209.30M	$195.10M	$188.20M
Free cash flow	$564.80M	$513.10M	$744.40M	$70.90M	-$112.10M	-$83.00M
Investing cash flow	-$63.30M	-$319.50M	-$1.64B	-$187.60M	-$149.90M	-$192.70M
Financing cash flow	-$130.30M	-$173.10M	$252.00M	-$265.80M	$48.80M	$155.80M
Share buybacks	$43.70M	$103.50M	$74.30M	$7.20M	$0	$0
Stock-based compensation	$21.00M	$25.40M	$48.40M	$51.60M	$42.10M	$45.90M
Depreciation & amortization	$48.80M	$52.70M	$283.60M	$457.20M	$453.40M	$442.00M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$742.60M	$711.00M	$637.00M	$727.10M	$707.80M	$692.80M	$613.90M	$699.90M	$723.60M	$619.80M	$630.90M	$618.90M
Cost of revenue	$360.00M	$378.90M	$361.00M	$374.80M	$381.70M	$349.50M	$339.00M	$364.30M	$403.20M	$356.00M	$358.00M	$329.30M
Gross profit	$382.60M	$332.10M	$276.00M	$352.30M	$326.10M	$343.30M	$274.90M	$335.60M	$320.40M	$263.80M	$272.90M	$289.60M
Research & development	$59.30M	$59.20M	$56.30M	$55.90M	$47.30M	$53.20M	$45.70M	$41.50M	$45.80M	$44.90M	$48.70M	$42.50M
Selling, general & admin	$187.60M	$204.70M	$188.20M	$186.40M	$187.50M	$187.00M	$178.00M	$186.90M	$194.40M	$199.30M	$189.70M	$182.70M
Operating income	$40.10M	-$1.76B	-$117.50M	$15.00M	-$100.40M	$32.60M	-$180.70M	-$704.80M	-$66.30M	-$31.80M	-$21.80M	-$7.50M
Interest expense	—	$39.00M	$41.00M	$42.90M	$40.60M	$40.00M	$40.50M	$46.10M	$51.00M	$51.10M	$54.70M	$55.40M
Pre-tax income	-$9.20M	-$1.80B	-$162.90M	-$28.80M	-$140.90M	-$8.80M	-$229.60M	-$756.90M	-$112.40M	-$79.50M	-$81.20M	-$62.90M
Income tax	-$16.20M	-$92.90M	-$15.20M	-$8.90M	$37.50M	$3.90M	$25.80M	-$23.90M	$18.30M	$12.30M	$11.70M	-$9.10M
Net income	$7.00M	-$1.71B	-$147.70M	-$19.90M	-$178.40M	-$12.70M	-$255.40M	-$733.00M	-$130.70M	-$91.80M	-$92.90M	-$53.80M
EBITDA	$155.50M	-$1.64B	-$1.40M	$128.10M	$8.90M	$139.70M	-$70.40M	-$592.70M	$46.20M	$81.10M	$94.90M	$112.10M
EPS (basic)	$0.11	$-25.50	$-2.20	$-0.30	$-2.62	$-0.19	$-3.77	$-10.78	$-1.90	$-1.35	$-1.36	$-0.78
EPS (diluted)	$0.11	$-25.50	$-2.20	$-0.30	$-2.62	$-0.19	$-3.77	$-10.78	$-1.90	$-1.35	$-1.36	$-0.78
Diluted shares	0	66.90M	67.10M	67.30M	100.00K	67.50M	67.70M	68.00M	100.00K	68.20M	68.30M	68.70M
Gross margin	51.5%	46.7%	43.3%	48.5%	46.1%	49.6%	44.8%	47.9%	44.3%	42.6%	43.3%	46.8%
Operating margin	5.4%	-247.3%	-18.4%	2.1%	-14.2%	4.7%	-29.4%	-100.7%	-9.2%	-5.1%	-3.5%	-1.2%
Net margin	0.9%	-239.9%	-23.2%	-2.7%	-25.2%	-1.8%	-41.6%	-104.7%	-18.1%	-14.8%	-14.7%	-8.7%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$118.90M	$78.50M	$107.00M	$143.70M	$98.30M	$127.10M	$151.70M	$98.10M	$169.80M	$140.40M	$123.40M	$166.40M
Short-term investments	$48.40M	$0	$0	$0	$0	—	—	—	—	—	—	—
Receivables	$303.30M	$271.70M	$269.50M	$294.90M	$282.40M	$286.00M	$275.00M	$386.50M	$417.00M	$359.90M	$352.00M	$375.50M
Inventory	$577.80M	$583.10M	$602.00M	$577.00M	$533.70M	$563.20M	$578.70M	$613.80M	$577.60M	$611.50M	$618.90M	$642.70M
Total current assets	$1.31B	$1.21B	$1.34B	$1.41B	$1.22B	$1.26B	$1.28B	$1.37B	$1.45B	$1.38B	$1.38B	$1.45B
Goodwill	$2.49B	$734.80M	$732.50M	$770.60M	$649.50M	$670.90M	$711.10M	$0	$0	—	—	—
Total assets	$8.56B	$6.70B	$6.69B	$6.80B	$6.42B	$6.46B	$6.38B	$5.68B	$5.77B	$5.63B	$5.72B	$5.78B
Total current liabilities	$833.80M	$779.80M	$932.40M	$1.03B	$998.80M	$1.05B	$1.14B	$767.90M	$966.10M	$962.40M	$993.40M	$1.07B
Short-term debt	$139.80M	$161.10M	$356.40M	$373.80M	$341.80M	$393.80M	$534.20M	$162.50M	$178.30M	$228.20M	$355.70M	$424.40M
Long-term debt	$2.42B	$2.24B	$2.21B	$2.18B	$2.49B	$2.11B	$2.07B	$2.50B	$2.70B	$2.46B	$2.54B	$2.51B
Total debt	$2.56B	$2.40B	$2.56B	$2.55B	$2.83B	$2.50B	$2.61B	$2.66B	$2.88B	$2.69B	$2.89B	$2.94B
Total liabilities	$3.56B	$3.40B	$3.52B	$3.61B	$3.44B	$3.46B	$3.59B	$3.64B	$3.85B	$3.78B	$3.94B	$3.99B
Shareholders' equity	$5.01B	$3.31B	$3.17B	$3.19B	$2.98B	$3.00B	$2.79B	$2.04B	$1.92B	$1.85B	$1.77B	$1.79B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$80.40M	-$700.00K	-$97.90M	$117.90M	$63.70M	$65.60M	-$46.80M	-$45.50M	$131.90M	-$33.00M	-$110.60M	$19.60M
Capital expenditures	$48.60M	$66.10M	$35.30M	$46.50M	$47.20M	$56.20M	$37.50M	$50.00M	$44.50M	$34.00M	$25.50M	$21.00M
Free cash flow	$31.80M	-$66.80M	-$133.20M	$71.40M	$16.50M	$9.40M	-$84.30M	-$95.50M	$87.40M	-$67.00M	-$136.10M	-$1.40M
Investing cash flow	-$55.10M	-$20.20M	-$35.30M	-$56.50M	-$37.90M	-$56.20M	-$33.00M	-$53.90M	-$49.60M	-$34.00M	-$107.30M	-$20.90M
Financing cash flow	-$57.80M	-$18.50M	$162.50M	-$26.30M	-$68.90M	$17.60M	$103.30M	$46.00M	-$11.10M	$37.60M	$200.60M	$44.10M
Share buybacks	$7.20M	—	—	—	—	—	—	—	—	—	—	—
Stock-based compensation	$12.30M	$9.00M	$11.20M	$12.30M	$9.60M	$11.60M	$12.80M	$10.70M	$10.80M	$10.70M	$12.00M	$12.00M
Depreciation & amortization	$115.40M	$114.90M	$116.10M	$113.10M	$109.30M	$107.10M	$110.30M	$112.10M	$112.50M	$112.90M	$116.70M	$119.60M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.